Have a feature idea you'd love to see implemented?
Let us know!
AORT Artivion Inc
Price (delayed)
$28.48
Market cap
$1.19B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.02
Enterprise value
$1.5B
Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins
Highlights
The net income has soared by 97% YoY and by 90% from the previous quarter
Artivion's EPS has surged by 97% YoY and by 90% QoQ
AORT's quick ratio has dropped by 67% since the previous quarter and by 60% year-on-year
Key stats
What are the main financial stats of AORT
Market
Valuations
Earnings
Shares outstanding
41.92M
Market cap
$1.19B
Enterprise value
$1.5B
Price to earnings (P/E)
N/A
Price to book (P/B)
3.92
Price to sales (P/S)
3.1
EV/EBIT
38.21
EV/EBITDA
21.21
EV/Sales
3.9
Revenue
$384.9M
Gross profit
$248.37M
Net income
-$851,000
EBIT
$39.28M
EBITDA
$70.75M
Free cash flow
$11.25M
Per share
Balance sheet
Liquidity
EPS
-$0.02
EPS diluted
-$0.02
Free cash flow per share
$0.27
Book value per share
$7.27
Revenue per share
$9.2
TBVPS
$9.32
Total assets
$803.14M
Total liabilities
$498.41M
Debt
$363.12M
Equity
$304.74M
Working capital
$135.12M
Debt to equity
1.19
Current ratio
1.88
Quick ratio
0.88
Net debt/EBITDA
4.34
Margins
Efficiency
Dividend
EBITDA margin
18.4%
Gross margin
64.5%
Net margin
-0.2%
Operating margin
10.2%
Return on assets
-0.1%
Return on equity
-0.3%
Return on invested capital
6.5%
Return on capital employed
6%
Return on sales
10.2%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
AORT stock price
How has the Artivion stock price performed over time
Intraday
1.82%
1 week
-1.56%
1 month
4.82%
1 year
59.37%
YTD
59.28%
QTD
6.99%
Financial performance
How have Artivion's revenue and profit performed over time
Revenue
$384.9M
Gross profit
$248.37M
Operating income
$39.38M
Net income
-$851,000
Gross margin
64.5%
Net margin
-0.2%
The net income has soared by 97% YoY and by 90% from the previous quarter
AORT's net margin has soared by 97% year-on-year and by 91% since the previous quarter
The company's operating income rose by 17% QoQ
The operating margin has grown by 13% since the previous quarter
Growth
What is Artivion's growth rate over time
Valuation
What is Artivion stock price valuation
P/E
N/A
P/B
3.92
P/S
3.1
EV/EBIT
38.21
EV/EBITDA
21.21
EV/Sales
3.9
Artivion's EPS has surged by 97% YoY and by 90% QoQ
The stock's price to book (P/B) is 45% more than its 5-year quarterly average of 2.7 and 23% more than its last 4 quarters average of 3.2
Artivion's equity has increased by 12% YoY and by 3.3% QoQ
The price to sales (P/S) is 24% higher than the last 4 quarters average of 2.5 and 19% higher than the 5-year quarterly average of 2.6
The company's revenue rose by 13% YoY and by 2.1% QoQ
Efficiency
How efficient is Artivion business performance
AORT's return on assets has surged by 97% year-on-year and by 91% since the previous quarter
AORT's ROE has soared by 97% YoY and by 90% QoQ
The ROIC is up by 38% QoQ
Artivion's return on sales has increased by 31% QoQ
Dividends
What is AORT's dividend history
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
Dividend history
Special dividends are included in TTM DPS and yield
Financial health
How did Artivion financials performed over time
The total assets is 61% greater than the total liabilities
AORT's quick ratio has dropped by 67% since the previous quarter and by 60% year-on-year
AORT's current ratio has dropped by 67% since the previous quarter and by 61% year-on-year
AORT's debt is 19% greater than its equity
Artivion's equity has increased by 12% YoY and by 3.3% QoQ
The debt to equity has contracted by 9% YoY and by 3.3% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.